Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Novartis reports positive top-line data from Phase IIIb Gilenya trial

Photomicrograph of a demyelinating multiple sclerosis lesion. Credit: Marvin 101.



Go Top